Personalized Cancer Treatment with Advanced Radiopharmaceuticals
In cancer care, there is no “one-size-fits-all” solution. Every patient is unique, and your treatment should reflect that.
At our centers, we design highly personalized treatment plans using next-generation radiopharmaceuticals that precisely target cancer cells while minimizing exposure to healthy tissue.
Through advanced molecular imaging, precision dosimetry, and innovative radioligand therapies, we tailor each approach to your specific diagnosis, tumor biology and personal goals.
"At Theranostics Centers of America, our goal is clear: precision in treatment, compassion in care, and clarity at every step."
What is Theranostics?
Theranostics is an advanced approach to cancer care that combines diagnosis and treatment into one highly precise strategy.
In prostate cancer, we use a specific biomarker called PSMA (Prostate-Specific Membrane Antigen).
PSMA is a receptor located on the surface of prostate cancer cells and is present in much higher amounts than on normal cells.
Because of this, PSMA allows us to both find and treat prostate cancer with remarkable precision.
How PSMA Theranostics Works
We believe in whole-person care, addressing the physical, emotional, and personal dimensions of healing.
Cancer affects more than the body; it can impact your thoughts, your relationships, your sense of stability, and even your sense of meaning.
Our team is committed to supporting you not only medically, but also mentally and emotionally, and respecting whatever gives you strength, resilience, and hope.
Whether that strength comes from family, community, faith, reflection, or personal values, we honor the full person behind the diagnosis.
1. Finding the Cancer (PSMA PET/CT Imaging)
We begin with a PSMA PET/CT scan.
During this scan, we inject a small amount of a radiopharmaceutical designed to attach specifically to the PSMA receptor on the surface of prostate cancer cells. Because prostate cancer cells express large amounts of this receptor, the tracer binds to those cells and “lights them up” on the scan.
• The PET portion shows the biological activity of the cancer.
• The CT portion provides detailed anatomical images.
When combined, PSMA PET/CT allows us to see:
- Exactly where the cancer is located
- Whether it has spread
- The extent and activity of the disease
This provides a precise map of prostate cancer throughout the body.
2. Monitoring Response (Post-Therapy SPECT/CT or Follow-Up Restaging PSMA PET/CT)
After treatment begins, we carefully monitor response using:
- Post-therapy SPECT/CT scans to evaluate radioligand distribution and tumor targeting.
- Restaging follow-up PSMA PET/CT scans to assess overall disease response
These imaging studies allow us to:
- Confirm that the therapy reached the intended targets
- Measure how the cancer is responding
- Detect any changes in disease burden
- Guide future treatment decisions
Monitoring ensures that therapy remains personalized and optimized for your specific disease.
3. Targeted Treatment (PSMA Radioligand Therapy)
Once we confirm that your cancer expresses PSMA, we can use a treatment designed to target it directly.
PSMA radioligand therapy uses a similar molecule to the one used for imaging — but instead of only helping us visualize the cancer, it carries a therapeutic radioactive particle.
This treatment:
- Travels through the bloodstream
- Binds to the PSMA receptor on prostate cancer cells
- Delivers radiation directly into those cells
The goal is to destroy cancer cells while minimizing exposure to surrounding healthy tissue.
TCA Health Care
Why Theranostics Is Different?
Traditional treatments can affect both cancerous and healthy cells.
Theranostics allows us to:
- Identify appropriate patients using biomarker imaging
- Deliver radiation precisely to cancer cells
- Monitor treatment response using advanced imaging
- Personalize therapy based on your specific tumor biology
This precision approach helps us fulfill our promise to deliver the highest level of patient care, using the most accurate and individualized information to optimize treatment decisions and improve outcomes.
But exceptional care goes beyond technology.
We believe in whole-person care, addressing the physical, emotional, and personal dimensions of healing.
Cancer affects more than the body; it can impact your thoughts, your relationships, your sense of stability, and even your sense of meaning.
Our team is committed to supporting you not only medically, but also mentally and emotionally, and respecting whatever gives you strength, resilience, and hope.
Whether that strength comes from family, community, faith, reflection, or personal values, we honor the full person behind the diagnosis.
Precision Care For Prostate Cancer.
Prostate cancer is a significant health concern for men, especially when it advances to a metastatic stage.
Precision Care For Neuroendocrine Tumors
Our Theranostics Centers specializes in treating neuroendocrine malignancies using Lutetium Lu-177 DOTATATE
Precision Treatment For Thyroid Cancer.
Our Theranostics centers offer advanced radiopharmaceutical treatments, including I-131 therapy, to treat thyroid cancer effectively.
Collaborative Care — Every Step of the Way
We work closely with your team of physicians to ensure your treatment plan remains seamless, precise, and fully aligned with your unique needs.
With a unified approach centered entirely on you, we provide timely updates, advanced imaging insights, and treatment data to help guide informed decisions throughout your journey.
Why Choose Us?
- Personalized Treatment Plans: Every patient is unique, and so is our approach to cancer care.
- Advanced Technology: : Using the latest in PET, SPECT imaging, and radiopharmaceutical therapy.
- Targeted Precision: : We focus on accuracy to minimize damage to healthy tissues.
- Expert Care Team: : Led by highly trained specialists in oncology, radiology, and nuclear medicine.